Fatima Al Kaabi

Fatima Al Kaabi

inventor United Arab Emirates

Fatima Al Kaabi is recognized as the youngest Emirati inventor, celebrated for her innovative contributions. During the 'Future Educators' segment of the 'Education First' forum, she shared her inspiring journey and highlighted the significant role teachers played in fostering her creativity and resilience.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
8,991
Power
391$
Sentiment
9.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United Arab Emirates 1 9.00 0.09% +0% 9,890,400 8,991 $430,000 391$
Totals 1 9,890,400 8,991 $430,000 391$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United Arab Emirates United Arab Emirates: Dr. Fatima Al Kaabi, the Director General of the Emirates Drug Authority, confirmed the adoption of the innovative treatment 'Inbifa' for heart failure. 9

Al Ittihad: "الإمارات للدواء" تعتمد "إنبيفا"(سوتاجليفلوزين) المبتكر لعلاج فشل القلب

United Arab Emirates United Arab Emirates: Dr. Fatima Al Kaabi, Director General of the Emirates Drug Authority, stated that the regulatory approval of the drug 'Itvisma' reflects the UAE's commitment to providing the latest advanced gene therapies to patients. 9

Al Ittihad: الإمارات تعتمد علاجاً لمرضى ضمور العضلات الشوكي

United Arab Emirates United Arab Emirates: Dr. Fatima Al Kaabi, the Chairwoman of the Emirates Biotechnology Research Center, emphasized the center's participation in the Abu Dhabi International Hunting and Equestrian Exhibition to showcase its innovations. 9

Al Ittihad: «مركز التكنولوجيا الحيوية» يشارك في «أبوظبي الدولي للصيد والفروسية»

United Arab Emirates United Arab Emirates: Dr. Fatima Al Kaabi, the Director General of the Emirates Drug Authority, announced that the UAE is the first country in the world to approve the innovative drug 'Tolperizone' for multiple sclerosis. 9

Al Ittihad: مدير عام مؤسسة الإمارات للدواء لـ «الاتحاد»: الإمارات الأولى عالمياً باعتماد دواء مبتكر للتصلب المتعدد

United Arab Emirates United Arab Emirates: Dr. Fatima Al Kaabi, the General Director of the Emirates Drug Authority, stated that this achievement reflects the success of the state's proactive policies in enhancing drug security. 9

Al Ittihad: "الإمارات للدواء" تعتمد عقار "جوسيلكوماب" لعلاج الأمراض المعوية الالتهابية